Breastcancer.org Podcast artwork

Experimental Elacestrant: A Standard of Care for Pre-Treated, Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer?

Breastcancer.org Podcast

English - December 19, 2021 13:19 - 12 minutes - 29.7 MB - ★★★★ - 35 ratings
Science Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Alcohol and Breast Cancer Risk

Next Episode: Aromatase Inhibitors versus Tamoxifen for Pre-Menopausal Women Diagnosed With Early-Stage, Hormone Receptor-Positive Disease